Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported SWK Q1 2026 Earnings EPS Beat Drives Positive Sentiment TEAD Q1 2026 Earnings Narrowed Loss Beats Expectations as Cost Discipline Shines DTW Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed BNR Q3 2022 Earnings Narrower Loss Surpasses Estimates Stock Declines Southern Missouri Bancorp Q1 2026 Earnings Narrow EPS Miss Amid Steady Operations